TipRanks
Advertisement
Advertisement

RLMD Stock Latest News

Relmada Therapeutics Announces Urology Chief Medical Officer Exit
Company AnnouncementsRelmada Therapeutics Announces Urology Chief Medical Officer Exit
1M ago
8K
RLMD
Relmada’s NDV-01 Bladder Cancer Trial Moves Into Phase 3: What Investors Should Watch
PremiumCompany Announcements
Relmada’s NDV-01 Bladder Cancer Trial Moves Into Phase 3: What Investors Should Watch
2M ago
RLMD
Relmada Therapeutics Earnings Call Highlights NDV-01 Path
PremiumCompany Announcements
Relmada Therapeutics Earnings Call Highlights NDV-01 Path
2M ago
RLMD
Relmada Highlights Q2 Results and NDV-01 Pipeline Progress
PremiumCompany Announcements
Relmada Highlights Q2 Results and NDV-01 Pipeline Progress
3M ago
8K
RLMD
Relmada Therapeutics reports Q2 EPS (11c), consensus (20c)
PremiumThe Fly
Relmada Therapeutics reports Q2 EPS (11c), consensus (20c)
3M ago
RLMD
Relmada Therapeutics Inc (RLMD) Q2 Earnings Cheat Sheet
PremiumPre-EarningsRelmada Therapeutics Inc (RLMD) Q2 Earnings Cheat Sheet
3M ago
RLMD
Relmada Therapeutics appoints Bipin Dalmia as chief business officer
Premium
The Fly
Relmada Therapeutics appoints Bipin Dalmia as chief business officer
3M ago
RLMD
Relmada Therapeutics names Bipin Dalmia chief business officer
Premium
The Fly
Relmada Therapeutics names Bipin Dalmia chief business officer
3M ago
RLMD
Relmada Therapeutics Appoints New Chief Business Officer
PremiumCompany Announcements
Relmada Therapeutics Appoints New Chief Business Officer
3M ago
8K
RLMD
Relmada Therapeutics joins Russell 2000, Russell 3000 Indexes
PremiumThe Fly
Relmada Therapeutics joins Russell 2000, Russell 3000 Indexes
4M ago
RLMD
Relmada Therapeutics initiated with a Buy at H.C. Wainwright
PremiumThe Fly
Relmada Therapeutics initiated with a Buy at H.C. Wainwright
4M ago
RLMD
Relmada Therapeutics Increases Authorized Shares After Shareholder Vote
PremiumCompany Announcements
Relmada Therapeutics Increases Authorized Shares After Shareholder Vote
5M ago
8K
RLMD
Relmada Therapeutics Charts Ambitious NDV-01 Phase 3 Path
PremiumCompany AnnouncementsRelmada Therapeutics Charts Ambitious NDV-01 Phase 3 Path
5M ago
RLMD
Relmada Therapeutics files automatic mixed securities shelf
Premium
The Fly
Relmada Therapeutics files automatic mixed securities shelf
5M ago
RLMD
Relmada Highlights NDV-01 Phase 2 Data, Phase 3 Plans
Premium
Company Announcements
Relmada Highlights NDV-01 Phase 2 Data, Phase 3 Plans
5M ago
8K
RLMD
Relmada Therapeutics initiated with an Overweight at Piper Sandler
PremiumThe Fly
Relmada Therapeutics initiated with an Overweight at Piper Sandler
7M ago
RLMD
Relmada Therapeutics Charts Aggressive Path After Earnings Call
PremiumCompany Announcements
Relmada Therapeutics Charts Aggressive Path After Earnings Call
7M ago
RLMD
Relmada Highlights NDV-01 Data, Funding in 2025 Results
PremiumCompany Announcements
Relmada Highlights NDV-01 Data, Funding in 2025 Results
7M ago
8K
RLMD
Relmada Therapeutics price target raised to $19 from $10 at Mizuho
PremiumThe Fly
Relmada Therapeutics price target raised to $19 from $10 at Mizuho
7M ago
RLMD
Relmada’s Withdrawn Phase 3 Bladder Cancer Trial: What It Means for RLMD Investors
PremiumCompany AnnouncementsRelmada’s Withdrawn Phase 3 Bladder Cancer Trial: What It Means for RLMD Investors
7M ago
RLMD
Relmada’s Withdrawn BOOST Trial Resets Expectations for NDV-01 and RLMD
Premium
Company Announcements
Relmada’s Withdrawn BOOST Trial Resets Expectations for NDV-01 and RLMD
7M ago
RLMD
Relmada Therapeutics Inc (RLMD) Q4 Earnings Cheat Sheet
Premium
Pre-Earnings
Relmada Therapeutics Inc (RLMD) Q4 Earnings Cheat Sheet
7M ago
RLMD

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >